These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Evaluation of a real-time polymerase chain reaction assay using analyte-specific reagents for detection of methicillin-resistant Staphylococcus aureus nasal carriage.
    Author: Fodrie TY, Allen SD, Blue DE, Gary P, Cheng L.
    Journal: Anal Quant Cytol Histol; 2009 Dec; 31(6):410-6. PubMed ID: 20698357.
    Abstract:
    OBJECTIVE: To validate a real-time polymerase chain reaction (PCR) assay for the detection of methicillin-resistant Staphylococcus aureus (MRSA) that is capable of accommodating 30 patient samples in a single batch without compromising the level of sensitivity and specificity associated with PCR testing. STUDY DESIGN: A real-time PCR analyte-specific reagent (ASR) assay was compared to conventional culture methods using dual swab samples collected from the nares of 151 patients. RESULTS: Of the 151 specimens, 49 (32%) were positive for MRSA by PCR, whereas 40 (26%) were positive by culture methods. The Roche LightCycler 2.0 (Roche Diagnostics, Indianapolis, Indiana, U.S.A.) and its associated ASRs were capable of analyzing 30 patient samples and 2 controls in < 2 hours. Current data suggest that 4-10% of our patient specimens harbor both coagulase negative Staphylococcus and S aureus in the same sample. Samples such as this are reflexed to culture, only 24% of which contain MRSA. Efficiency in the laborato-ry was greatly improved. The sensitivity, specificity, positive predictive value and negative predictive value were 100%, 92%, 82% and 100%, respectively. CONCLUSION: The Roche LightCycler 2.0 PCR platform is a sensitive and efficient screening method for determining the nasal carriage of MRSA with a rapid turnaround time in the clinical laboratory.
    [Abstract] [Full Text] [Related] [New Search]